Halliburton Secures Iraq Oilfield Development Deal; WAIT Rating Unchanged

What happened

Halliburton announced an integrated contract to develop Iraq's Bin Umar and Sindbad oil fields, aiming to boost production via advanced operations, which aligns with the master report's focus on international awards as a key catalyst. However, the report notes that international revenue fell 2% YoY in FY2025 and Middle East/Asia declined 4%, with 2026 guidance described as 'stable' rather than accelerating. While this deal is a positive step, it is just one data point in a needed series of awards to validate the bull case. The thesis hinges on further evidence of international order conversion and cost savings to offset North America weakness (frac spreads down 19% YoY). Thus, the news is supportive but does not yet change the WAIT rating, as the stock at $37.60 already prices in successful execution.

Implication

This contract reinforces the international growth narrative but does not alter the fundamental challenge: North America utilization remains weak and pricing concessions have already occurred. The bull case requires sustained international award momentum, with this deal contributing to the completion tools order book, but the bear case (25% probability) remains viable if U.S. pricing deteriorates further or the IRS dispute materializes (~$640M). At $37.60, the stock offers limited upside without confirming cost saves and international conversion. Therefore, maintain the WAIT rating and look for additional evidence in the next 6–12 months. The base case at $38 implies a successful margin defense, but current valuation leaves little room for error.

Thesis delta

The Iraq deal provides incremental support for the international growth pillar, but the core thesis remains unchanged. The stock still prices in successful margin defense and cost savings that are unconfirmed. The shift is from 'waiting for evidence' to 'initial evidence received, but more needed' before upgrading.